Jay Flatley

Type: Person
Name: Jay Flatley
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Illumina reports higher Q3 net income, provides annual guidance

Illumina, Inc., a developer of life science tools and integrated systems for the analysis of genetic variation and function, has reported that net income for the third quarter ended September 28, 2014 was $93.49 million, or $0.63 per diluted share, compared ... [Published Individual.com - Oct 23 2014]
First reported Oct 20 2014 - Updated Oct 21 2014 - 6 reports

Illumina up 10% on strongest growth since 2011, raises 2014 guidance

Illumina CEO Jay FlatleyGenomic sequencing seems to have come of age with Illumina ($ILMN) as a substantial driver and beneficiary. During the third quarter, the company achieved astonishing revenue growth of 35% to $481 million over the same quarter ... [Published FierceMedicalDevices - Oct 21 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

How To Land Projects in California

Municipalities find ways around Golden State barriers to attracting capital investment.Until recently, California's state-level economic development cupboard was looking a little bare - its 400 redevelopment agencies were dissolved in February 2012, property ... [Published Site Selection Magazine - Oct 16 2014]
First reported Oct 06 2014 - Updated Oct 07 2014 - 1 reports

Illumina, Inc. To Announce Third Quarter 2014 Financial Results On Monday, October 20, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2014 following the close of market on Monday, October 20, 2014.On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay Flatley, ... [Published BioSpace - Oct 06 2014]
First reported Oct 06 2014 - Updated Oct 07 2014 - 2 reports

Illumina to Announce Third Quarter 2014 Financial Results on Monday, October 20, 2014

. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2014 following the close of market on Monday, October 20, 2014.On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay Flatley, Chief Executive Officer, Francis deSouza, ... [Published Wall Street Select - Oct 06 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

New technology brings about a revolution in medical care

DNA sequencing is revolutionising the diagnosis and treatment of everything from cancer to Down syndrome at breakneck speed, changing health care forever. Incredibly, only one company—Illumina—is making it all possible. It's just getting startedImage: ... [Published Forbes India - Sep 26 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Morgan Stanley Global Healthcare Conference in New York on September 9, 2014. The live webcast is scheduled to begin at 2:55 ... [Published Business Wire Health News - Aug 27 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

The One to Beat

Forbes' Matthew Herper profiles Jay Flatley, the company, and the field he pushed to new heights. read more ... [Published The Daily Scan from GenomeWeb - Aug 21 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Illumina CEO on genome sequencing technology

Illumina CEO Jay Flatley discusses 2Q earnings and genome sequencing technology. ... [Published FOX Business - Video - Jul 24 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 3 reports

Illumina to Announce Second Quarter 2014 Financial Results on Wednesday, July 23, 2014

SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2014 following the close of market on Wednesday, July 23, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern ... [Published EON Science - Jul 09 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Reaction to the $1,000 Genome

System promises to sequence tens of thousands of human whole genomes a year in a single laboratory. What do the first customers think? Life science technology company Illumina recently launched a sequencing platform that it claims will enable the $1,000 ... [Published I Am Biotech - Jun 24 2014]
First reported May 05 2014 - Updated May 05 2014 - 3 reports

Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May and June

SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at three upcoming investment conferences. Illumina will webcast its presentation at the Bank of America Merrill Lynch ... [Published EON Science - May 05 2014]

Quotes

Jay Flatley, CEO said: "illumina experienced tremendous momentum in the third quarter, with strong shipments in hiseq x, nextseq and miseq, as well as the associated consumables, resulting in record financial results. with the most extensive sequencing portfolio available, we are well-positioned for continued long-term growth as we develop and address the large and untapped market opportunities ahead of us."
Flatley, though, said that he expects fewer shipments this quarter due to the company's "estimates of customer readiness."
"illumina experienced tremendous momentum in the third quarter, with strong shipments in hiseq x, nextseq and miseq, as well as the associated consumables, resulting in record financial results" said Chief Executive Jay Flatley

More Content

All (24) | News (13) | Reports (0) | Blogs (11) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Illumina reports higher Q3 net income, provides... [Published Individual.com - Oct 23 2014]
Illumina up 10% on strongest growth since 2011,... [Published FierceMedicalDevices - Oct 21 2014]
Illumina's (ILMN) CEO Jay Flatley on Q3 2014 Re... [Published Austin American Statesman - Oct 21 2014]
Illumina's (ILMN) CEO Jay Flatley on Q3 2014 Re... [Published Seeking Alpha - Oct 21 2014]
Gene Sequencer Illumina's Q3 Well In Order [Published Yahoo! Finance - Oct 21 2014]
Illumina Spikes 10% On Q3 Earnings Beat [Published Yahoo! Finance - Oct 20 2014]
Illumina Profit Surges, Lifts Outlook; Shares U... [Published RTTNews.com - Oct 20 2014]
How To Land Projects in California [Published Site Selection Magazine - Oct 16 2014]
Illumina, Inc. To Announce Third Quarter 2014 F... [Published BioSpace - Oct 06 2014]
Illumina to Announce Third Quarter 2014 Financi... [Published Wall Street Select - Oct 06 2014]
Illumina to Announce Third Quarter 2014 Financi... [Published Business Wire Health News - Oct 06 2014]
New technology brings about a revolution in med... [Published Forbes India - Sep 26 2014]
Illumina to Webcast Live Presentation at the Mo... [Published Business Wire Health News - Aug 27 2014]
The One to Beat [Published The Daily Scan from GenomeWeb - Aug 21 2014]
Illumina CEO on genome sequencing technology [Published FOX Business - Video - Jul 24 2014]
Illumina to Announce Second Quarter 2014 Financ... [Published EON Science - Jul 09 2014]
Illumina to Announce Second Quarter 2014 Financ... [Published Business Wire Science: Science News - Jul 09 2014]
Illumina to Announce Second Quarter 2014 Financ... [Published Business Wire Health News - Jul 09 2014]
Reaction to the $1,000 Genome [Published I Am Biotech - Jun 24 2014]
Illumina to Webcast Live Presentation at Upcomi... [Published EON Science - May 05 2014]
Illumina to Webcast Live Presentation at Upcomi... [Published Business Wire Science: Science News - May 05 2014]
Illumina to Webcast Live Presentation at Upcomi... [Published Business Wire Health News - May 05 2014]
WuXi purchases Illumina HiSeq X Ten sequencing ... [Published PharmaBiz - Mar 11 2014]
J.P. Morgan: Pharma’s Agenda for 2014 [Published Pharmaceutical Executive - Jan 20 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Illumina to Announce Third Quarter 2014 Financi... [Published Business Wire Health News - Oct 06 2014]
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2014 following the close of market on Monday, October 20, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay Flatley, ...
Illumina to Webcast Live Presentation at the Mo... [Published Business Wire Health News - Aug 27 2014]
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Morgan Stanley Global Healthcare Conference in New York on September 9, 2014. The live webcast is scheduled to begin at 2:55 ...
The One to Beat [Published The Daily Scan from GenomeWeb - Aug 21 2014]
Forbes' Matthew Herper profiles Jay Flatley, the company, and the field he pushed to new heights. read more ...
Illumina CEO on genome sequencing technology [Published FOX Business - Video - Jul 24 2014]
Illumina CEO Jay Flatley discusses 2Q earnings and genome sequencing technology. ...
Illumina to Announce Second Quarter 2014 Financ... [Published EON Science - Jul 09 2014]
SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2014 following the close of market on Wednesday, July 23, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.